Skip to main content
SpringerLink
Log in

Clinical Approaches to the Patient with a Failing Fontan Procedure

  • Congenital Heart Disease (RA Krasuski, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

The Fontan operation has been nothing short of revolutionary in its influence on the modern management of patients born with functionally univentricular hearts. The vast majority of these individuals are now surviving well into adulthood. In the 45 years since its introduction, however, there has been increasing recognition of Fontan survivors as a vulnerable population with an altered physiology that has remarkably broad, adverse impact on their long-term health. In this review, the authors discuss the varied manifestations, both cardiac and extracardiac, of the failing Fontan circulation and potential therapeutic options. In addition, a general clinical approach to the patient presenting with Fontan failure is proposed. Ultimately, the key to improving our care and understanding of the Fontan population lies in multi-institutional collaboration and partnership between subspecialty cardiologists and specialists in other organ systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Khairy P, Poirier N, Mercier LA. Univentricular heart. Circulation. 2007;115(6):800–12. doi:10.1161/CIRCULATIONAHA.105.592378.

    Article  PubMed  Google Scholar 

  2. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26(3):240. doi:10.1136/thx.26.3.240.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Valente AM, Landzberg MJ, Powell AJ. Essential atlas of cardiovascular disease. New York: New York: Springer; 2009. p. 231–46.

    Google Scholar 

  4. d’Udekem Y, Iyengar AJ, Galati JC, et al. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation. 2014;130(11 Suppl 1):S32–8. doi:10.1161/CIRCULATIONAHA.113.007764. This report from a large, comprehensive national registry demonstrates the shifting demographic and improving late outcomes of survivors of Fontan palliation.

  5. Khairy P, Fernandes SM, Mayer JE, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation. 2008;117(1):85–92. doi:10.1161/circulationaha.107.738559.

    Article  PubMed  Google Scholar 

  6. Mori M, Aguirre AJ, Elder RW, et al. Beyond a broken heart: circulatory dysfunction in the failing Fontan. Pediatr Cardiol. 2014. doi:10.1007/s00246-014-0881-y.

    PubMed  Google Scholar 

  7. Anderson PA, Sleeper LA, Mahony L, et al. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol. 2008;52(2):85–98. doi:10.1016/j.jacc.2008.01.074.

    Article  PubMed  PubMed Central  Google Scholar 

  8. d’Udekem Y, Xu MY, Galati JC, et al. Predictors of survival after single-ventricle palliation: the impact of right ventricular dominance. J Am Coll Cardiol. 2012;59(13):1178–85. doi:10.1016/j.jacc.2011.11.049.

    Article  PubMed  Google Scholar 

  9. Elder RW, McCabe NM, Veledar E, et al. Risk factors for major adverse events late after Fontan palliation. Congenit Heart Dis. 2015;10(2):159–68. doi:10.1111/chd.12212.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Warnes CA. Transposition of the great arteries. Circulation. 2006;114(24):2699–709. doi:10.1161/CIRCULATIONAHA.105.592352.

    Article  PubMed  Google Scholar 

  11. Liu VJ, Yong MS, d’Udekem Y, et al. Outcomes of atrioventricular valve operation in patients with Fontan circulation. Ann Thorac Surg. 2015;99(5):1632–8. doi:10.1016/j.athoracsur.2015.01.035.

    Article  PubMed  Google Scholar 

  12. Wong DJ, Iyengar AJ, Wheaton GR, et al. Long-term outcomes after atrioventricular valve operations in patients undergoing single-ventricle palliation. Ann Thorac Surg. 2012;94(2):606–13. doi:10.1016/j.athoracsur.2012.03.058. discussion 13.

    Article  PubMed  Google Scholar 

  13. Pundi KN, Johnson JN, Dearani JA, et al. 40-year follow-up after the Fontan operation: long-term outcomes of 1,052 patients. J Am Coll Cardiol. 2015;66(15):1700–10. doi:10.1016/j.jacc.2015.07.065. This study presents the long-term outcomes among a large, single-center cohort of Fontan patients with the longest period of follow-up yet reported.

  14. Elder RW, McCabe NM, Hebson C, et al. Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study. Int J Cardiol. 2013. doi:10.1016/j.ijcard.2013.06.008.

    PubMed  PubMed Central  Google Scholar 

  15. Hebson CL, McCabe NM, Elder RW, et al. Hemodynamic phenotype of the failing Fontan in an adult population. Am J Cardiol. 2013;112(12):1943–7. doi:10.1016/j.amjcard.2013.08.023.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Rodefeld MD, Coats B, Fisher T, et al. Cavopulmonary assist for the univentricular Fontan circulation: von Karman viscous impeller pump. J Thorac Cardiovasc Surg. 2010;140(3):529–36. doi:10.1016/j.jtcvs.2010.04.037.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Lacour-Gayet FG, Lanning CJ, Stoica S, et al. An artificial right ventricle for failing Fontan: in vitro and computational study. Ann Thorac Surg. 2009;88(1):170–6. doi:10.1016/j.athoracsur.2009.03.091.

    Article  PubMed  Google Scholar 

  18. Simpson KE, Cibulka N, Lee CK, et al. Failed Fontan heart transplant candidates with preserved vs impaired ventricular ejection: 2 distinct patient populations. J Heart Lung Trans: Off Publ Int Soc Heart Trans. 2012;31(5):545–7. doi:10.1016/j.healun.2012.02.003.

    Article  Google Scholar 

  19. Griffiths ER, Kaza AK. Wyler von Ballmoos MC et al. Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg. 2009;88(2):558–63. doi:10.1016/j.athoracsur.2009.03.085. discussion 63–4.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Mitchell MB, Campbell DN, Ivy D, et al. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J Thorac Cardiovasc Surg. 2004;128(5):693–702. doi:10.1016/j.jtcvs.2004.07.013.

    Article  PubMed  Google Scholar 

  21. Hebert A, Mikkelsen UR, Thilen U, et al. Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (treatment with endothelin receptor antagonist in Fontan patients, a randomized, placebo-controlled, double-blind study measuring peak oxygen consumption) study. Circulation. 2014;130(23):2021–30. doi:10.1161/CIRCULATIONAHA.113.008441. This randomized, double-blind, placebo-controlled study suggests a potential therapeutic role for bosentan in the Fontan population.

  22. Goldberg DJ, French B, McBride MG, et al. Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation. 2011;123(11):1185–93. doi:10.1161/CIRCULATIONAHA.110.981746.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. John AS, Johnson JA, Khan M, et al. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation. J Am Coll Cardiol. 2014;64(1):54–62. doi:10.1016/j.jacc.2014.04.025. This is a contemporary reexamination of clinical outcomes in patients who present with protein-losing enteropathy after the Fontan operation.

  24. Banka P, McElhinney DB, Bacha EA, et al. What is the clinical utility of routine cardiac catheterization before a Fontan operation? Pediatr Cardiol. 2010;31(7):977–85. doi:10.1007/s00246-010-9736-3.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Firdouse M, Agarwal A, Chan AK, et al. Thrombosis and thromboembolic complications in Fontan patients: a literature review. Clin Appl Thromb/Hemost: Off J Int Acad Clin Appl Thromb/Hemost. 2014;20(5):484–92. doi:10.1177/1076029613520464.

    Article  Google Scholar 

  26. Ohuchi H, Yasuda K, Miyazaki A, et al. Prevalence and predictors of haemostatic complications in 412 Fontan patients: their relation to anticoagulation and haemodynamics. Eur J Cardiothorac Surg: Off J Eur Assoc Cardiothoracic Surg. 2015;47(3):511–9. doi:10.1093/ejcts/ezu145.

    Article  Google Scholar 

  27. d’Udekem Y, Iyengar AJ, Cochrane AD, et al. The Fontan procedure—Contemporary techniques have improved long-term outcomes. Circulation. 2007;116(11):I157–64. doi:10.1161/circulationaha.106.676445.

    PubMed  Google Scholar 

  28. Yap SC, Harris L, Silversides CK, et al. Outcome of intra-atrial re-entrant tachycardia catheter ablation in adults with congenital heart disease: negative impact of age and complex atrial surgery. J Am Coll Cardiol. 2010;56(19):1589–96. doi:10.1016/j.jacc.2010.04.061.

    Article  PubMed  Google Scholar 

  29. Giannico S, Hammad F, Amodeo A, et al. Clinical outcome of 193 extracardiac Fontan patients: the first 15 years. J Am Coll Cardiol. 2006;47(10):2065–73. doi:10.1016/j.jacc.2005.12.065.

    Article  PubMed  Google Scholar 

  30. Stephenson EA, Lu M, Berul CI, et al. Arrhythmias in a contemporary Fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study. J Am Coll Cardiol. 2010;56(11):890–6. doi:10.1016/j.jacc.2010.03.079.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Caruthers RL, Kempa M, Loo A, et al. Demographic characteristics and estimated prevalence of Fontan-associated plastic bronchitis. Pediatr Cardiol. 2013;34(2):256–61. doi:10.1007/s00246-012-0430-5.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Avitabile CM, Goldberg DJ, Dodds K, et al. A multifaceted approach to the management of plastic bronchitis after cavopulmonary palliation. Ann Thorac Surg. 2014;98(2):634–40. doi:10.1016/j.athoracsur.2014.04.015. This article provides a thorough overview of the current management of plastic bronchitis in Fontan patients.

  33. Hraska V. Decompression of thoracic duct: new approach for the treatment of failing Fontan. Ann Thorac Surg. 2013;96(2):709–11. doi:10.1016/j.athoracsur.2013.02.046.

    Article  PubMed  Google Scholar 

  34. Mertens L, Hagler DJ, Sauer U, et al. Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg. 1998;115(5):1063–73.

    Article  CAS  PubMed  Google Scholar 

  35. Rychik J. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis. 2007;2(5):288–300. doi:10.1111/j.1747-0803.2007.00116.x.

    Article  PubMed  Google Scholar 

  36. Murch SH, Winyard PJ, Koletzko S, et al. Congenital enterocyte heparan sulphate deficiency with massive albumin loss, secretory diarrhoea, and malnutrition. Lancet (LondEngl). 1996;347(9011):1299–301.

    Article  CAS  Google Scholar 

  37. Westphal V, Murch S, Kim S, et al. Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation. Am J Pathol. 2000;157(6):1917–25. doi:10.1016/s0002-9440(10)64830-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Uzun O, Wong JK, Bhole V, et al. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan. Ann Thorac Surg. 2006;82(6):e39–40. doi:10.1016/j.athoracsur.2006.08.043.

    Article  PubMed  Google Scholar 

  39. Schwartz MC, Sullivan L, Cohen MS, et al. Hepatic pathology may develop before the Fontan operation in children with functional single ventricle: an autopsy study. J Thorac Cardiovasc Surg. 2012;143(4):904–9. doi:10.1016/j.jtcvs.2011.08.038.

    Article  PubMed  Google Scholar 

  40. Schwartz MC, Sullivan LM, Glatz AC, et al. Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery. Pediatr Cardiol. 2013;34(1):135–42. doi:10.1007/s00246-012-0402-9.

    Article  PubMed  Google Scholar 

  41. Asrani SK, Warnes CA, Kamath PS. Hepatocellular carcinoma after the Fontan procedure. N Engl J Med. 2013;368(18):1756–7. doi:10.1056/NEJMc1214222.

    Article  CAS  PubMed  Google Scholar 

  42. Ewe SH, Tan JL. Hepatocellular carcinoma—a rare complication post Fontan operation. Congenit Heart Dis. 2009;4(2):103–6. doi:10.1111/j.1747-0803.2009.00255.x.

    Article  Google Scholar 

  43. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg. 2005;129(6):1348–52.

    Article  PubMed  Google Scholar 

  44. Ho SS, Brown R, Fitzgibbon B. Hepatocellular carcinoma with cardiac cirrhosis. Med J Aust. 1990;152(10):553–4.

    CAS  PubMed  Google Scholar 

  45. Saliba T, Dorkhom S, O’Reilly EM, et al. Hepatocellular carcinoma in two patients with cardiac cirrhosis. Eur J Gastroenterol Hepatol. 2010;22(7):889–91. doi:10.1097/MEG.0b013e32832e2bec.

    Article  PubMed  Google Scholar 

  46. Johnson JA, Cetta F, Graham RP, et al. Identifying predictors of hepatic disease in patients after the Fontan operation: a postmortem analysis. J Thorac Cardiovasc Surg. 2012. doi:10.1016/j.jtcvs.2012.09.005.

    Google Scholar 

  47. Kendall TJ, Stedman B, Hacking N, et al. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol. 2008;61(4):504–8.

    Article  CAS  PubMed  Google Scholar 

  48. Wu FM, Jonas MM, Opotowsky AR, et al. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. J Heart Lung Transplant. 2015;34(7):883–91. doi:10.1016/j.healun.2015.01.993.

    Article  PubMed  Google Scholar 

  49. Asrani SK, Asrani NS, Freese DK, et al. Congenital heart disease and the liver. Hepatology. 2012;56(3):1160–9. doi:10.1002/hep.25692.

    Article  PubMed  Google Scholar 

  50. Assenza GE, Graham DA, Landzberg MJ, et al. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart. 2013;99(7):491–6. doi:10.1136/heartjnl-2012-303347heartjnl-2012-303347.

    Article  PubMed  Google Scholar 

  51. Fredriksen PM, Therrien J, Veldtman G, et al. Lung function and aerobic capacity in adult patients following modified Fontan procedure. Heart. 2001;85(3):295–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Opotowsky AR, Landzberg MJ, Earing MG, et al. Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity. Am J Physiol Heart Circ Physiol. 2014;307(1):H110–7. doi:10.1152/ajpheart.00184.2014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Dechert BE, Deal BJ. An integrated approach to the care of adult patients with prior atriopulmonary Fontan surgery. J Pediatr Health Care: Off Publ Natl Assoc Pediatr Nurse Assoc Pract. 2008;22(4):246–53. doi:10.1016/j.pedhc.2007.08.016.

    Article  Google Scholar 

  54. Poh CL, Cochrane A, Galati JC, et al. Ten-year outcomes of Fontan conversion in Australia and New Zealand demonstrate the superiority of a strategy of early conversion dagger. Eur J Cardiothoracic Surg: Off J Eur Assoc Cardiothoracic Surg. 2015. doi:10.1093/ejcts/ezv112.

    Google Scholar 

  55. Rossano JW, Shaddy RE. Heart transplant after the Fontan operation. Cardiol Young. 2013;23(6):841–6. doi:10.1017/S1047951113001662.

    Article  PubMed  Google Scholar 

  56. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation. 2008;118(23):2395–451. doi:10.1161/CIRCULATIONAHA.108.190811.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Pediatric Cardiology, Department of Pediatrics and Internal Medicine, Yale School of Medicine, New Haven, CT, USA

    Robert W. Elder

  2. Division of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA

    Fred M. Wu

Authors
  1. Robert W. Elder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fred M. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fred M. Wu.

Ethics declarations

Conflict of Interest

Robert W. Elder and Fred M. Wu declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Congenital Heart Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elder, R.W., Wu, F.M. Clinical Approaches to the Patient with a Failing Fontan Procedure. Curr Cardiol Rep 18, 44 (2016). https://doi.org/10.1007/s11886-016-0716-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-016-0716-y

Keywords

Search

Navigation